Atlas Trials

Clinical Trial for Valuation of the Effectiveness of Lactoferrine in the Prevention of Sepsis in New Premature Born. Bimonitorization of the Antinflammatory Mechanisms, Antioxidants and the Intestinal Microbiote.

Clinical trial NCT03472170 · UNKNOWN

Trial details

NCT number
NCT03472170
Sponsor
Maimónides Biomedical Research Institute of Córdoba
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
SEPSIS SYNDROME
Start date
2017-05-04
Primary completion
2020-03-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.